Novo Nordisk, unscathed by COVID-19, enters ‘strike mode’ with diabetes launch Rybelsus esagonowsky Thu, 08/06/2020 – 10:03
Category: Uncategorized
Analysts to Bristol Myers Squibb: Can I-O hit Opdivo really return to growth? arlene.weintraub Thu, 08/06/2020 – 10:51
Alexion hires first chief diversity officer, following pharma peers and social sentiment beth.bulik Thu, 08/06/2020 – 10:59
Findings show that MIS-C is a post-infectious syndrome distinct from Kawasaki disease and may help guide treatment decisions.
One of the most dangerous effects of coronavirus is the inability to breathe on your own – requiring […]
Covid-19Pre-surgery shielding is liftedPatients in England having elective surgery no longer need to self-isolate for 14 days before […]
I disagree with Khunti and colleagues that the report by Public Health England (PHE) on the impact of […]
Taken by surpriseDespite widespread criticism of significance testing, doctors, scientists, and journal editors continue to use P values […]
Who could disagree with Roderick and colleagues’ clear and sensible proposals for moving contact tracing onto a footing […]
